FIELD: medicine.
SUBSTANCE: the present innovation deals with antimycotic composition that includes either antibody or antigen-binding fragment being specific to the epitope of mycotic protein of thermal shock, and antimycotic agent for treating mycotic infections, where fungus is resistant to the agent mentioned per se. Moreover, a kit for treating mycotic diseases is also suggested.
EFFECT: increased number of antimycotic means.
11 cl, 23 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF FULVIC ACID FOR TREATMENT OF VARIOUS CONDITIONS AND DISEASES | 2010 |
|
RU2535037C2 |
| THERAPY OF MYCOSES | 2005 |
|
RU2380116C2 |
| COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS | 2021 |
|
RU2824066C1 |
| CHIMERIC RECOMBINANT INTERFERON ALPHA-2B, HAVING ANTIFUNGAL ACTIVITY | 2024 |
|
RU2823607C1 |
| NOVEL DOSAGE FORM FOR TREATING MYCOTIC INFECTION | 2010 |
|
RU2481100C2 |
| COMPOSITIONS AND METHODS OF TREATING ZYGOMYCOSIS AND OTHER FUNGOID DISEASES | 2007 |
|
RU2464024C2 |
| METHOD FOR TREATMENT OF FUNGAL ULCER OF CORNEA | 2021 |
|
RU2802388C2 |
| DERIVATIVES OF NYSTATIN AND THEIR APPLICATION AS ANTIFUNGAL AGENTS | 2008 |
|
RU2488590C2 |
| MIXED METAL COMPLEXES BASED ON 5-(4-METHYLPHENYL)-2,2'-BIPYRIDINE AND (TETRAFLUOR) SALICYLIC ACIDS, HAVING ANTIBACTERIAL AND FUNGISTATIC ACTIVITY | 2020 |
|
RU2737435C1 |
| ANTIMICROBIAL PEPTIDES CONTAINING ARGININE- AND LYSINE-CONTAINING MOTIVE | 2005 |
|
RU2396273C2 |
